Quick Answer
Doximity, Inc. reported R&D Expense of $93.04 million for fiscal year 2025.
Doximity, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $93.04M | +13.5% |
| 2024 | $81.98M | +2.2% |
| 2023 | $80.19M | +28.6% |
| 2022 | $62.35M | +42.1% |
| 2021 | $43.87M | +35.3% |
| 2020 | $32.44M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $34.59M | +54.3% | +14.5% |
| September 30, 2025 | $30.20M | +30.0% | +12.7% |
| June 30, 2025 | $26.80M | +18.7% | +19.5% |
| December 31, 2024 | $22.42M | +12.4% | -3.5% |
| September 30, 2024 | $23.24M | +16.4% | +3.0% |
| June 30, 2024 | $22.57M | +2.9% | +13.2% |
| December 31, 2023 | $19.95M | -2.8% | -0.1% |
| September 30, 2023 | $19.96M | +4.5% | -9.0% |
- Doximity, Inc. showed an increase of +13.5% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, Doximity, Inc.’s r&d expense has grown by 186.8% (from $32.44 million to $93.04 million).
- The most recent figure is from Doximity, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 20, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: